Sasaki Y, Asahiyama M, Tanaka T, Yamamoto S, Murakami K, Kamiya W1, Matsumura Y , Osawa T, Anai M, Fruchart JC, Aburatani H, Sakai J , Kodama T.
Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content.
Sci Rep, 5, 10, 7818, 2020. [DOI] [PubMed] [Journal Web Site]